# Anti-Inflammatory and Antioxidant Properties of a New Mixture of Vitamin C, Collagen Peptides, Resveratrol, and Astaxanthin in Tenocytes: Molecular Basis for Future Applications in Tendinopathies

**Authors:** Monica Marzagalli, Stefania Battaglia, Michela Raimondi, Fabrizio Fontana, Marco Cozzi, Francesca R. Ranieri, Roberto Sacchi, Valeria Curti, Patrizia Limonta

PMC · DOI: 10.1155/2024/5273198 · Mediators of Inflammation · 2024-07-30

## TL;DR

A new mix of vitamin C, collagen, resveratrol, and astaxanthin reduces inflammation and oxidative stress in tendon cells, offering potential for treating tendinopathies.

## Contribution

The study introduces a novel combination of natural compounds with synergistic anti-inflammatory and antioxidant effects in tenocytes.

## Key findings

- The mix significantly reduces IL-1β secretion, NF-κB translocation, and MMP-2 production in response to inflammation.
- The combination effectively counteracts hydrogen peroxide-induced ROS production in tenocytes.
- The compounds show a synergistic effect greater than individual components in reducing proinflammatory and prooxidant stimuli.

## Abstract

Tendinopathy is one of the most frequent musculoskeletal disorders characterized by sustained tissue inflammation and oxidative stress, accompanied by extracellular matrix remodeling. Patients suffering from this pathology frequently experience pain, swelling, stiffness, and muscle weakness. Current pharmacological interventions are based on nonsteroidal anti-inflammatory drugs; however, the effectiveness of these strategies remains ambiguous. Accumulating evidence supports that oral supplementation of natural compounds can provide preventive, and possibly curative, effects. Vitamin C (Vit C), collagen peptides (Coll), resveratrol (Res), and astaxanthin (Asx) were reported to be endowed with potential beneficial effects based on their anti-inflammatory and antioxidant activities. Here, we analyzed the efficacy of a novel combination of these compounds (Mix) in counteracting proinflammatory (IL-1β) and prooxidant (H2O2) stimuli in human tenocytes. We demonstrated that Mix significantly impairs IL-6-induced IL-1β secretion, NF-κB nuclear translocation, and MMP-2 production; notably, a synergistic effect of Mix over the single compounds could be observed. Moreover, Mix was able to significantly counteract H2O2-triggered ROS production. Together, these results point out that Mix, a novel combination of Vit C, Coll, Resv, and Asx, significantly impairs proinflammatory and prooxidant stimuli in tenocytes, mechanisms that contribute to the onset of tendinopathies.

## Linked entities

- **Proteins:** IL6 (interleukin 6), IL1B (interleukin 1 beta), NFKB1 (nuclear factor kappa B subunit 1), MMP2 (matrix metallopeptidase 2)
- **Chemicals:** Vitamin C (PubChem CID 54670067), Resveratrol (PubChem CID 5056), Astaxanthin (PubChem CID 5281224), H2O2 (PubChem CID 784)
- **Diseases:** tendinopathy (MONDO:0100010)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, MIXL1 (Mix paired-like homeobox) [NCBI Gene 83881] {aka MILD1, MIX, MIXL}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** Tendinopathies (MESH:D052256), Inflammatory (MESH:D007249), pain (MESH:D010146), stiffness (MESH:C566112), muscle weakness (MESH:D018908), swelling (MESH:D004487), musculoskeletal disorders (MESH:D009140)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11303056/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11303056/full.md

## References

118 references — full list in the complete paper: https://tomesphere.com/paper/PMC11303056/full.md

---
Source: https://tomesphere.com/paper/PMC11303056